On this page
Mark A Hudak
Insider
First SEC filing: March 23, 2021 · Latest: March 23, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 19, 2021 | GPRE | F | 1,385 | $25.63 | $35,498 | 61,292 Direct | -2.21% | Disposed | -40.9% (price as of 2026-10-06) |
| March 19, 2021 | GPRE | A | 1,839 | · | · | 63,131 Direct | +3.00% | Acquired | (price as of 2026-10-06) |
| Feb. 19, 2021 | GPRE | F | 1,079 | $27.27 | $29,424 | 62,677 Direct | -1.69% | Disposed | -44.4% (price as of 2026-10-06) |
| Feb. 18, 2021 | GPRE | A | 7,912 | $18.96 | $150,012 | 63,756 Direct | +14.17% | Acquired | -20.0% (price as of 2026-10-06) |
| March 19, 2020 | GPRE | F | 652 | $4.48 | $2,921 | 55,844 Direct | -1.15% | Disposed | 238.4% (price as of 2026-10-06) |
| March 18, 2020 | GPRE | A | 9,868 | $10.64 | $104,996 | 56,496 Direct | +21.16% | Acquired | 42.5% (price as of 2026-10-06) |
| March 2, 2020 | GPRE | F | 2,044 | $12.68 | $25,918 | 46,628 Direct | -4.20% | Disposed | 19.6% (price as of 2026-10-06) |
| Feb. 19, 2020 | GPRE | F | 1,079 | $13.56 | $14,631 | 48,672 Direct | -2.17% | Disposed | 11.8% (price as of 2026-10-06) |
| March 19, 2019 | GPRE | F | 432 | $16.97 | $7,331 | 49,751 Direct | -0.86% | Disposed | -10.7% (price as of 2026-10-06) |
| March 2, 2019 | GPRE | F | 1,208 | $15.64 | $18,893 | 50,183 Direct | -2.35% | Disposed | -3.1% (price as of 2026-10-06) |
| Feb. 19, 2019 | GPRE | A | 6,519 | $15.34 | $100,001 | 51,391 Direct | +14.53% | Acquired | -1.2% (price as of 2026-10-06) |
| Feb. 12, 2019 | GPRE | F | 2,928 | $14.44 | $42,280 | 44,872 Direct | -6.13% | Disposed | 5.0% (price as of 2026-10-06) |
| March 19, 2018 | GPRE | A | 4,408 | $18.15 | $80,005 | 46,147 Direct | +10.56% | Acquired | -16.5% (price as of 2026-10-06) |
| March 19, 2018 | GPRE | A | 1,653 | $18.15 | $30,002 | 47,800 Direct | +3.58% | Acquired | -16.5% (price as of 2026-10-06) |
| March 2, 2018 | GPRE | F | 1,209 | $19.20 | $23,213 | 41,739 Direct | -2.82% | Disposed | -21.0% (price as of 2026-10-06) |
| Feb. 12, 2018 | GPRE | F | 2,654 | $18.35 | $48,701 | 42,948 Direct | -5.82% | Disposed | -17.4% (price as of 2026-10-06) |
| Feb. 6, 2018 | GPRE | F | 1,089 | $16.80 | $18,295 | 45,602 Direct | -2.33% | Disposed | -9.8% (price as of 2026-10-06) |
| March 2, 2017 | GPRE | A | 12,346 | $24.30 | $300,008 | 46,691 Direct | +35.95% | Acquired | -37.6% (price as of 2026-10-06) |
| Feb. 12, 2017 | GPRE | F | 2,781 | $24.90 | $69,247 | 34,345 Direct | -7.49% | Disposed | -39.1% (price as of 2026-10-06) |
| Feb. 7, 2017 | GPRE | F | 618 | $23.20 | $14,338 | 37,126 Direct | -1.64% | Disposed | -34.7% (price as of 2026-10-06) |
| Feb. 6, 2017 | GPRE | F | 1,183 | $22.45 | $26,558 | 37,744 Direct | -3.04% | Disposed | -32.5% (price as of 2026-10-06) |
| Feb. 12, 2016 | GPRE | A | 25,984 | $13.47 | $350,004 | 38,927 Direct | +200.76% | Acquired | 12.5% (price as of 2026-10-06) |
| Feb. 7, 2016 | GPRE | F | 618 | $17.44 | $10,778 | 12,943 Direct | -4.56% | Disposed | -13.1% (price as of 2026-10-06) |
| Feb. 6, 2016 | GPRE | F | 1,183 | $17.44 | $20,632 | 13,561 Direct | -8.02% | Disposed | -13.1% (price as of 2026-10-06) |
| Feb. 7, 2015 | GPRE | F | 618 | $26.53 | $16,396 | 14,744 Direct | -4.02% | Disposed | -42.9% (price as of 2026-10-06) |
| Feb. 6, 2015 | GPRE | A | 9,424 | $26.53 | $250,019 | 15,362 Direct | +158.71% | Acquired | -42.9% (price as of 2026-10-06) |
| Feb. 7, 2014 | GPRE | A | 6,556 | $22.88 | $150,001 | 6,556 Direct | · | Acquired | -33.7% (price as of 2026-10-06) |
| Feb. 7, 2014 | GPRE | F | 618 | $22.88 | $14,140 | 5,938 Direct | -9.43% | Disposed | -33.7% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.